About CoLAB AccelBio

AccelBio is a collaborative laboratory that aims to be the bridge that brings biomedical science closer to the market. With a set of partners that cover all the necessary capacities and expertise to drive drug discovery.
AccelBio selects fundamental research discoveries and cutting-edge technology platforms and tools and guides the transformation of breakthrough science into validated and investment-worthy assets.

AccelBio bridges academic research groups and start-ups with industry-standard drug discovery capabilities - target validation, assay development, high-throughput screening, in silico modelling, medicinal chemistry, in vitro and in vivo testing, IP support and business development. Innovative platforms are also being developed within a well-defined R&I agenda that will further boost drug discovery.
By providing these capacities and specialized expertise, AccelBio will de-risk drug discovery assets until they are ready to be out-licensed to industry or established as the foundation of new spin-off companies.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology Research
location icon
Headquarter
Biocant Park, Parque Tecnológico de Cantanhede, Cantanhede, PT
description icon
Founded
2021
description icon
Keywords
Biotechnology, Research, Pharmaceutical, Biotech, Life Sciences, Health, Neuroscience, Technology Transfer, Drug Discovery, Business Development, Oncology, Drug Development, Immunology, Translational Research, Drug Design, Preclinical Studies, High Throughput Screening, Development And Innovation, Organoids, Antibody Drug Conjugates, Multiomics, Target Discovery And Validation

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more